Seamaty Makes Waves at Medlab Middle East 2024, Showcasing Cutting-Edge POCT Solutions

Dubai, UAE, February 6, 2024 – Chengdu Seamaty Technology Co., Ltd., a leading provider of top-notch point-of-care testing (POCT) medical equipment since 2012, made a splash at the Medlab Middle East 2024 exhibition(February 5-8th), showcasing its best-selling and latest products to a global audience.

Seamaty's booth(Z2-E50) attracted visitors from around the world eager to explore the company's innovative diagnostic solutions. The company's experienced sales staff warmly welcomed guests, providing insightful demonstrations and in-depth explanations of their featured products.

Unveiling the Future of POC Testing:

A key highlight was the SD3 fully automatic biochemical analyzer, making its debut at the exhibition. This revolutionary analyzer, not yet officially released, drew significant interest with its advanced features and streamlined design. Alongside the SD3, Seamaty presented its established portfolio, including:

• SMT120 and SD1 fully automatic dry biochemical analyzers: Proven best-sellers renowned for their accuracy, efficiency, and user-friendliness.
• SMT-70 semi-automatic biochemical analyzer: A versatile option for clinics and laboratories seeking a cost-effective yet reliable solution.
• CLIA analyzer: Meeting the highest quality standards for clinical laboratory testing.
• SG1 and SE1 handheld blood gas electrolyte analyzers: Seamaty's star products, offering portable and rapid analysis for critical care settings.

Global Reach, Local Commitment:

Seamaty's participation at Medlab Middle East underscores its commitment to serving the ever-evolving needs of the healthcare industry in the region. With global subsidiaries spanning countries like Russia, Germany, Thailand, and Egypt, and collaborations with partners in over 100 countries, Seamaty ensures its products and services are readily accessible to healthcare professionals worldwide.

Looking Ahead:

Seamaty's successful showing at Medlab Middle East 2024 reflects its unwavering dedication to innovation and excellence. The company remains committed to developing cutting-edge POC testing solutions that empower healthcare professionals to deliver faster, more accurate diagnoses and treatments, ultimately improving patient outcomes around the globe.

About Seamaty:

Chengdu Seamaty Technology Co., Ltd. is a leading provider of high-quality POC testing solutions. Since 2012, the company has been committed to providing innovative and reliable medical equipment to healthcare professionals worldwide. Seamaty's dedication to quality is evident in its ISO 13485:2016 certification and its state-of-the-art production facilities. With a global network of subsidiaries and partners, Seamaty ensures its products and services are readily available to healthcare professionals in over 100 countries and regions.